Publications

Export 34 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Depressive Disorder, Major  [Clear All Filters]
Journal Article
Jollant F.  2015.  Add-on lithium for the treatment of unipolar depression: too often forgotten? J Psychiatry Neurosci. 40(1):E23-4.
Burns RJ, Deschênes SS, Schmitz N.  2016.  Associations between coping strategies and mental health in individuals with type 2 diabetes: Prospective analyses.. Health Psychol. 35(1):78-86.
Deschênes SS, Burns RJ, Schmitz N.  2015.  Associations between depression, chronic physical health conditions, and disability in a community sample: A focus on the persistence of depression.. J Affect Disord. 179:6-13.
Deschênes SS, Burns RJ, Schmitz N.  2015.  Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: findings from the 2012 Canadian Community Health Survey--Mental Health (CCHS-MH).. J Psychosom Res. 78(2):137-42.
Berlim M, Van den Eynde F, Tovar-Perdomo S, Chachamovich E, Zangen A, Turecki G.  2014.  Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.. World J Biol Psychiatry. 15(7):570-8.
Kedzior KKarolina, Gierke L, Gellersen HMarie, Berlim M.  2016.  Cognitive functioning and deep transcranial magnetic stimulation (DTMS) in major psychiatric disorders: A systematic review.. J Psychiatr Res. 75:107-15.
McGirr A, Berlim M.  2014.  A comment on Fond and colleagues' systematic review and meta-analysis of ketamine in the treatment of depressive disorders (Psychopharmacology 2014; Jul 20 [Epub ahead of print]).. Psychopharmacology (Berl). 231(19):3907-8.
Meng X, D'Arcy C.  2015.  Comorbidity between lifetime eating problems and mood and anxiety disorders: results from the Canadian Community Health Survey of Mental Health and Well-being.. Eur Eat Disord Rev. 23(2):156-62.
Chung JKu, Plitman E, Nakajima S, M Chakravarty M, Caravaggio F, Gerretsen P, Iwata Y, Graff-Guerrero A.  2016.  Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.. J Geriatr Psychiatry Neurol. 29(3):149-59.
Roy L, Crocker AG, Nicholls TL, Latimer E, Ayllon AReyes.  2014.  Criminal behavior and victimization among homeless individuals with severe mental illness: a systematic review.. Psychiatr Serv. 65(6):739-50.
Kedzior KKarolina, Gellersen HMarie, Brachetti AKatharina, Berlim M.  2015.  Deep transcranial magnetic stimulation (DTMS) in the treatment of major depression: An exploratory systematic review and meta-analysis.. J Affect Disord. 187:73-83.
Wang JLi, Patten S, Sareen J, Bolton J, Schmitz N, MacQueen G.  2014.  Development and validation of a prediction algorithm for use by health professionals in prediction of recurrence of major depression.. Depress Anxiety. 31(5):451-7.
Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR et al..  2016.  Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.. BMC Psychiatry. 16:105.
Oh G, Wang S-C, Pal M, Chen ZFei, Khare T, Tochigi M, Ng C, Yang YA, Kwan A, Kaminsky ZA et al..  2015.  DNA modification study of major depressive disorder: beyond locus-by-locus comparisons.. Biol Psychiatry. 77(3):246-55.
McGirr A, Van den Eynde F, Tovar-Perdomo S, Fleck MPA, Berlim M.  2015.  Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.. J Affect Disord. 173:216-20.
Chandley MJ, Szebeni A, Szebeni K, Crawford JD, Stockmeier CA, Turecki G, Kostrzewa RM, Ordway GA.  2014.  Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression.. Int J Neuropsychopharmacol. 17(10):1569-78.
Galfalvy H, Haghighi F, Hodgkinson C, Goldman D, Oquendo MA, Burke A, Huang Y-Y, Giegling I, Rujescu D, Bureau A et al..  2015.  A genome-wide association study of suicidal behavior.. Am J Med Genet B Neuropsychiatr Genet. 168(7):557-63.
Treadway MT, Waskom ML, Dillon DG, Holmes AJ, Park MTae M, M Chakravarty M, Dutra SJ, Polli FE, Iosifescu DV, Fava M et al..  2015.  Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression.. Biol Psychiatry. 77(3):285-94.
Maheu M, Lopez JP, Crapper L, Davoli MA, Turecki G, Mechawar N.  2015.  MicroRNA regulation of central glial cell line-derived neurotrophic factor (GDNF) signalling in depression.. Transl Psychiatry. 5:e511.
Lopez JPablo, Lim R, Cruceanu C, Crapper L, Fasano C, Labonte B, Maussion G, Yang JP, Yerko V, Vigneault E et al..  2014.  miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment.. Nat Med. 20(7):764-8.
Gariépy G, Thombs BD, Kestens Y, Kaufman JS, Blair A, Schmitz N.  2015.  The Neighbourhood Built Environment and Trajectories of Depression Symptom Episodes in Adults: A Latent Class Growth Analysis.. PLoS One. 10(7):e0133603.
Godlewska BR, Near J, Cowen PJ.  2015.  Neurochemistry of major depression: a study using magnetic resonance spectroscopy.. Psychopharmacology (Berl). 232(3):501-7.
Stergiopoulos V, Cusi A, Bekele T, Skosireva A, Latimer E, Schütz C, Fernando I, Rourke SB.  2015.  Neurocognitive impairment in a large sample of homeless adults with mental illness.. Acta Psychiatr Scand. 131(4):256-68.
McGirr A, Van den Eynde F, Chachamovich E, Fleck MPA, Berlim M.  2014.  Personality dimensions and deep repetitive transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a pilot trial on five-factor prediction of antidepressant response.. Neurosci Lett. 563:144-8.
Mamdani F, Berlim M, Beaulieu M-M, Turecki G.  2014.  Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder.. World J Biol Psychiatry. 15(2):135-44.

Pages